VivCyte Overview
- Year Founded
-
2015
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
VivCyte General Information
Description
Developer of cell cryopreservation designed for mammalian cell lines. The company offers chemically defined cell freezing media, serum-free culture supplements, custom medium formulations, formulation screening, and medium optimization, enabling life science research organizations to preserve cell lines and support lymphocyte cultures.
Contact Information
Website
www.vivcyte.comCorporate Office
- 16 Cavendish court
- DRTC Suite 415
- Lebanon, NH 03766
- United States
Corporate Office
- 16 Cavendish court
- DRTC Suite 415
- Lebanon, NH 03766
- United States
VivCyte Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | Completed | Generating Revenue |
VivCyte Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Dartmouth Regional Technology Center | Accelerator/Incubator |
VivCyte FAQs
-
When was VivCyte founded?
VivCyte was founded in 2015.
-
Where is VivCyte headquartered?
VivCyte is headquartered in Lebanon, NH.
-
What industry is VivCyte in?
VivCyte’s primary industry is Biotechnology.
-
Is VivCyte a private or public company?
VivCyte is a Private company.
-
What is VivCyte’s current revenue?
The current revenue for VivCyte is .
-
Who are VivCyte’s investors?
Dartmouth Regional Technology Center has invested in VivCyte.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process